THE PETRIZZO GROUP, INC. for FATE THERAPEUTICS, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUSTIN LEBLANC | — |
| TJ PETRIZZO | — |
Defense DEF
Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUSTIN LEBLANC | — |
| TJ PETRIZZO | — |
Budget/Appropriations BUD
Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUSTIN LEBLANC | — |
| TJ PETRIZZO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.